Sanofi (SANp)
Euronext Paris • Healthcare
June 2, 2026 at 15:30 UTC
About Sanofi
Sanofi is a healthcare company that discovers, manufactures, and supplies medicines and vaccines used in clinical practice. Clinical programs target evidence that can be translated into labeling, and medical information supports safe use after approval. Plants operate to validated procedures, and logistics are planned so pharmacies, hospitals, and clinics receive steady supply. Regional teams handle access and pharmacovigilance under local rules while global functions maintain shared standards. Reporting sits inside the healthcare sector with a focus on operating facts rather than narrative goals. The company describes its role as maintaining continuity for health systems while adding new options through measured change. The stance is process first, with patient safety and data integrity kept at the center of decisions.
Analyst Ratings
Fundamentals & Financials
TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.
Income Statement
Balance Sheet
Financial Highlights
Dividends History
Split History
Earnings Calendar
Technical Indicators
Sanofi's Technical Indicators Summary
Banco Santander is trading under its short, medium and long EMAs with momentum negative and a subdued RSI, which together explain the bearish stance. ADX indicates limited trend strength, so the move lower lacks strong directional conviction, while on-balance volume shows net selling pressure. The classic pivot sits above the current price and moving averages are aligned to the downside, giving technical weight to the bear case. Volatility is moderate and MACD remains weak. Technical takeaway: Bearish — price below multiple EMAs with selling pressure and only modest trend strength.
| Indicator | Value |
|---|---|
RSI (14) | 39.22 |
Stochastic %K (14, 3, 3) | 33.75 |
CCI (20) | -65.79 |
WPR (14) | -85.03 |
Momentum (10) | -1.78 |
MFI | 45.22 |
MACD Level (12, 26) | -0.72 |
Bollinger Bands | $71.65 - $78.22 |
ATR (14) | $1.56 (2.13%) |
ADX (14) | 13.92 |
OBV | 4,264,182 |
Classic Pivot Point | $74.50 |
Fibonacci Pivot Point | $74.50 |
Simple Moving Averages | $74.94 - $76.12(5 indicators) |
Exponential Moving Averages | $75.32 - $80.77(5 indicators) |
Get premium market insights delivered directly to your inbox.
Today's Snapshot
The day concluded on a slightly softer note, with SANp maintaining a small -0.92% downside gap and finishing at about 73.48. The day closed with light sector weakness (-0.87%), providing a gentle headwind. Into the close, SANp still showed subdued interest, with volume at 0.34× its norm.
Price Change
from €73.3 close
+€0.11
Trading Volume
Below avg (2.4M)
801.8K
vs S&P 500 Today
Underperforming Market
-0.77%
52-Week Position
Near lows
9%
Updated: June 2, 2026 at 15:07 UTC
Quote Summary
SANp Headlines
Big Pharma Updates: Trials, Deals and Ratings
April 27, 2026
Japan clears Dupixent for bullous pemphigoid
March 24, 2026
Goldman’s Top Healthcare Picks Gain Fresh Catalysts
March 15, 2026
Azoria ETFs shut, Novartis India stake sold, tariff shock
February 20, 2026